US20210338988A1 - Vascular closure device and related methods - Google Patents
Vascular closure device and related methods Download PDFInfo
- Publication number
- US20210338988A1 US20210338988A1 US16/864,865 US202016864865A US2021338988A1 US 20210338988 A1 US20210338988 A1 US 20210338988A1 US 202016864865 A US202016864865 A US 202016864865A US 2021338988 A1 US2021338988 A1 US 2021338988A1
- Authority
- US
- United States
- Prior art keywords
- sheath
- tissue tract
- blood vessel
- procoagulant
- vascular access
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 179
- 230000002792 vascular Effects 0.000 title claims abstract description 151
- 239000003805 procoagulant Substances 0.000 claims abstract description 93
- 239000000463 material Substances 0.000 claims abstract description 70
- 210000004369 blood Anatomy 0.000 claims abstract description 56
- 239000008280 blood Substances 0.000 claims abstract description 54
- 239000012530 fluid Substances 0.000 claims abstract description 49
- 238000011010 flushing procedure Methods 0.000 claims abstract description 30
- 238000007789 sealing Methods 0.000 claims abstract description 15
- 210000004204 blood vessel Anatomy 0.000 claims description 122
- 239000002904 solvent Substances 0.000 claims description 12
- 238000004891 communication Methods 0.000 claims description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- 229920001651 Cyanoacrylate Polymers 0.000 claims description 3
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 claims description 3
- 230000017531 blood circulation Effects 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims 1
- 230000015271 coagulation Effects 0.000 abstract description 5
- 238000005345 coagulation Methods 0.000 abstract description 5
- 210000001519 tissue Anatomy 0.000 description 68
- 230000008569 process Effects 0.000 description 17
- 239000000243 solution Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 208000005189 Embolism Diseases 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 108090000190 Thrombin Proteins 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 229960004072 thrombin Drugs 0.000 description 4
- 239000000499 gel Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 208000005764 Peripheral Arterial Disease Diseases 0.000 description 2
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 239000000701 coagulant Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 102100026735 Coagulation factor VIII Human genes 0.000 description 1
- 101710204168 Coagulation factor VIII Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000009087 False Aneurysm Diseases 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000013152 interventional procedure Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/0061—Implements located only on one side of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/0065—Type of implements the implement being an adhesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/00659—Type of implements located only on one side of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00672—Locating means therefor, e.g. bleed back lumen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
- A61M2039/0258—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body for vascular access, e.g. blood stream access
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0415—Plasma
- A61M2202/0425—Thrombin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/15—Detection of leaks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
Definitions
- the present invention relates to a vascular closure device and related methods for achieving hemostasis at a vascular access site after a surgical procedure.
- a positioning catheter may be introduced into a blood vessel via a puncture in the blood vessel, and thereafter various procedural tools (e.g., a balloon catheter) may be introduced into the blood vessel via the positioning catheter to perform a procedure at a surgical site located near or some distance away from the puncture.
- procedural tools and positioning catheter are removed, an open puncture in the blood vessel (e.g., an arteriotomy, if the blood vessel is an artery) and an open subcutaneous tissue tract will remain, and require action to prevent the patient from significant blood loss.
- the present disclosure comprises a method of performing a vascular closure procedure at a vascular access site that has been formed through a wall of a blood vessel in a body part of a patient, the method comprising: inserting a sheath into a tissue tract defined in the body part, the tissue tract being in fluid flow communication with an interior of the blood vessel via the vascular access site such that blood from the blood vessel may enter the tissue tract; temporarily sealing the vascular access site so that blood from the blood vessel may no longer enter the tissue tract; flushing the tissue tract with a flushing fluid via the sheath such that the tissue tract is substantially cleared of blood; injecting a procoagulant material into the tissue tract via the sheath at a location adjacent the vascular access site; and unsealing the vascular access site so that blood from the blood vessel interacts with the procoagulant material at the location.
- the present disclosure comprises a vascular closure device comprising: a sheath having a wall, the wall defining a cavity, the cavity including a plurality of flush openings located in the wall adjacent a first end of the cavity and a port located at a second end of the cavity, the port and the plurality of flush openings being in fluid flow communication, the sheath being adapted to be inserted within a tissue tract defined in a body part of a patient to a position adjacent a vascular access site formed through a wall of a blood vessel in the body part, the tissue tract being in fluid flow communication with an interior of the blood vessel via the vascular access site such that blood from the blood vessel may enter the tissue tract; wherein, when the sheath is inserted within the tissue tract, a flushing fluid may be introduced into the cavity through the port such that the flushing fluid exits the cavity through the plurality of flush openings such that the sheath and the tissue tract are substantially cleared of blood.
- the present disclosure comprises a method of performing a vascular closure procedure at a vascular access site that has been formed through a wall of a blood vessel in a body part of a patient, the method comprising: inserting a sheath into a tissue tract defined in the body part, the tissue tract being in fluid flow communication with an interior of the blood vessel via the vascular access site such that blood from the blood vessel may enter the tissue tract; inserting a positioning catheter through the sheath into the blood vessel, the positioning catheter comprising a cavity and a nozzle slidably attached thereto such that a position of a distal end of the nozzle is adjustable with respect to a distal end of the cavity; temporarily sealing the vascular access site so that blood from the blood vessel may no longer enter the tissue tract; flushing the tissue tract with a flushing fluid via the sheath or the nozzle such that the tissue tract is substantially cleared of blood; injecting a procoagulant material into the tissue tract via the nozzle at a location adjacent the vascular access site; and unse
- FIG. 1 is a front view of an exemplary vascular access device according to an embodiment of the present disclosure
- FIG. 2 is a side view thereof
- FIG. 3 is a cross-sectional view thereof, taken along line 3 - 3 of FIG. 2 ;
- FIG. 4 is a perspective view of an exemplary body part of a patient where a vascular access procedure may occur
- FIG. 5 is a partial cross-sectional view of the body part of FIG. 4 taken along line 5 - 5 of FIG. 4 , showing an exemplary blood vessel on which a vascular access procedure will be performed;
- FIGS. 6A and 6B are partial cross-sectional views of the exemplary vascular access device of FIGS. 1-3 and a positioning catheter in operation to close the blood vessel of FIG. 5 according to a first vascular closure method of the present disclosure;
- FIG. 7 is a partial cross-sectional view of the exemplary vascular access device of FIGS. 1-3 and the positioning catheter of FIGS. 6A and 6B further in operation to close the blood vessel of FIGS. 5-6B according to the first vascular closure method;
- FIG. 8 is a partial cross-sectional view of the exemplary vascular access device of FIGS. 1-3 6 A, and 6 B and the positioning catheter of FIGS. 6A-7 in yet further operation to close the blood vessel of FIGS. 5-7 according to the first vascular closure method;
- FIG. 9 is a partial cross-sectional view of the exemplary vascular access device of FIGS. 1-3 and 6A-8 and the positioning catheter of FIGS. 6A-8 in even further operation to close the blood vessel of FIGS. 5-8 according to the first vascular closure method;
- FIG. 10 is a partial cross-sectional view of the exemplary vascular access device of FIGS. 1-3 and 6A-9 in further operation to close the blood vessel of FIGS. 5-9 according to the first vascular closure method;
- FIG. 11 is a partial cross-sectional view of a bandage in operation to close the body part of FIGS. 4-10 according to the first vascular closure method;
- FIG. 12 is a partial cross-sectional view of an alternative vascular access device according to the vascular access device of FIGS. 1-3 and 6A-10 and the positioning catheter of FIGS. 6A-9 in operation to close the blood vessel of FIG. 5 according to a second vascular closure method of the present disclosure;
- FIG. 13 is a partial cross-sectional view of the alternative vascular access device of FIG. 12 and the positioning catheter of FIGS. 6A-9 and 12 in operation to close the blood vessel of FIGS. 5 and 12 according to the second vascular closure method;
- FIG. 14 is a partial cross-sectional view of the alternative vascular access device of FIGS. 12 and 13 and the positioning catheter of FIGS. 6A-9, 12, and 13 in further operation to close the blood vessel of FIGS. 5, 12, and 13 according to the second vascular closure method;
- FIG. 15 is a partial cross-sectional view of the alternative vascular access device of FIGS. 12-14 and the positioning catheter of FIGS. 6A-9 and 12-14 in yet further operation to close the blood vessel of FIGS. 5 and 12-14 according to the second vascular closure method;
- FIG. 16 is a partial cross-sectional view of the alternative vascular access device of FIGS. 12-15 and the positioning catheter of FIGS. 6A-9 and 12-15 in even further operation to close the blood vessel of FIGS. 5 and 12-15 according to the second vascular closure method;
- FIG. 17 is a partial cross-sectional view of the exemplary vascular access device of FIGS. 12-16 in yet further operation to close the blood vessel of FIGS. 5 and 12-16 according to the second vascular closure method;
- FIG. 18 is a partial cross-sectional view of the bandage of FIG. 11 in operation to close the body part of FIGS. 4-17 according to the second vascular closure method;
- FIG. 19 is a flowchart representative of a first method according to the present disclosure of performing an internal vascular procedure utilizing a known vascular access method and the first vascular closure method of FIGS. 6A-11 ;
- FIG. 20 illustrates the flowchart of FIG. 19 with a first block of the flowchart expanded
- FIG. 21 illustrates the flowchart of FIG. 19 with a second block of the flowchart expanded
- FIG. 22 illustrates the flowchart of FIG. 19 with a third block of the flowchart expanded
- FIG. 23 is a flowchart representative of a second method according to the present disclosure of performing an internal vascular procedure utilizing a known vascular access method and the second vascular closure method of FIGS. 12-18 ;
- FIG. 24 illustrates the flowchart of FIG. 23 with a block of the flowchart expanded.
- proximal and distal should be understood to refer to a frame of reference from the vantage of a surgeon or other clinician using the device or performing the method, with “proximal” referring to a position closer to the clinician and “distal” referring to a position closer to the vascular access site.
- adjacent should be understood to encompass both “directly in physical contact with” and also “in close proximity to.” For example, with respect to the location within a tissue tract above a vascular access site where a procoagulant material comes into contact with and begins to interact with blood, unless otherwise specified, “adjacent” should be understood to mean a location both in direct physical contact with the vascular access site or otherwise in close proximity thereto.
- POD Peripheral Arterial Disease
- vascular access may be warranted for a number of other reasons, including surgical procedures that are to be performed some distance remote from the vascular access site. After such a procedure is complete, the vascular access site and open tissue tract through which access to the blood vessel was gained must be closed to prevent significant blood loss from the patient.
- intra- and/or extra-vascular solutions for covering and sealing an arteriotomy and other vascular access sites (e.g., venous access sites) exist.
- vascular access sites e.g., venous access sites
- intra-vascular component there is a risk of this component dislodging and causing an embolism or other complications.
- existing solutions that include only an extra-vascular component continue to require compression of the access site for several minutes after removal of the devices from the tissue tract—whether manually or via a pressure-supplying device (e.g., a band with an inflatable balloon assembly)—because the sealing of the arteriotomy provided by these extra-vascular devices is imperfect such that blood will continue to leak from the arteriotomy.
- a pressure-supplying device e.g., a band with an inflatable balloon assembly
- vascular closure device and related methods that reduce and/or eliminate the need to apply pressure to a vascular access site without the need to leave any sealing component in an intravascular position after a vascular access procedure is not believed to exist.
- the present disclosure describes a new vascular access device and related methods that are specifically configured to close a vascular access site with little to no application of pressure and without the need to leave an intravascular sealing component.
- the device and methods according to the present disclosure provide improvements through the delivery of procoagulant material (e.g., a fluid or gel) as close as possible to the arteriotomy, which leads to improved adhesion of the partially-coagulated plug of mixed blood and procoagulant to the extravascular portion of the blood vessel atop the arteriotomy, as well as more complete filling of the subcutaneous tissue tract.
- procoagulant material e.g., a fluid or gel
- the device and methods according to the present disclosure provide improvements over the known prior art, in which procoagulant is delivered into the tissue tract from a position remote from the arteriotomy (e.g., via a sidearm of a positioning catheter that is located well above the skin surface), which leads to coagulation well up in the cavity of the sheath or tissue tract (i.e., far from the arteriotomy), which is believed to reduce the quality and adhesive effectiveness of the plug formed by the mixed blood and procoagulant material.
- the inventor has conceived of multiple methods of delivering a procoagulant material at or adjacent to the arteriotomy through various filling and injection methods, which causes the procoagulant material to mix with fresh blood exiting the arteriotomy and results in improved coagulation and reduced or eliminated need for the later application of pressure to the vascular access site to achieve hemostasis.
- the present application discloses various methods of filling the tissue tract with a procoagulant material.
- the procoagulant material used according to any of the embodiments herein may be in the form of a liquid, viscous liquid, suspension, gel, foam, or a mixture of any thereof.
- Suitable compounds for the procoagulant material include, but are not limited to, cyanoacrylate (CA), polyurethane, thrombin, a mixture of thrombin and collagen, a mixture of thrombin and gelatin, a mixture of thrombin and fibrinogen, and mixtures of any thereof.
- the procoagulant material(s) may also be mixed with a solvent, for example but not limited to dimethyl sulfoxide (DMSO), to form a procoagulant mixture that is in a viscous liquid, suspension, gel, or foam form, or a mixture of two or more of these forms.
- a solvent for example but not limited to dimethyl sulfoxide (DMSO)
- DMSO dimethyl sulfoxide
- the solvent and procoagulant may be introduced together into the tissue tract and/or adjacent to the arteriotomy in a variety of orders, for example: the solvent is introduced immediately after the procoagulant material; the procoagulant material is introduced immediately after the solvent; the solvent and procoagulant material are introduced at alternating times in three or more steps (e.g., procoagulant-solvent-procoagulant-etc. or solvent-procoagulant-solvent-etc.; or the procoagulant material and the solvent are introduced simultaneously.
- FIGS. 12-17 show a second embodiment of a vascular access device 100 ′ according to the above-noted inventive concept. It should be understood that all parts in the vascular access device 100 ′ bearing the same reference numerals as the respective parts in the vascular access device 100 are functionally identical thereto, unless otherwise discussed herein. Accordingly, the vascular access device 100 ′ will not be described in detail below, and the discussion below of the vascular access device 100 should be understood to also apply to the vascular access device 100 , mutatis mutandis. As shown in FIGS.
- the vascular access device 100 is designed to deliver blood procoagulant (e.g., via a filling step or injecting step) to a location at or very near a vascular access site, as shown in FIGS. 6A-18 and as would be understood by a person having ordinary skill in the art.
- the vascular access device 100 includes a sheath 104 , an indicator 106 (e.g., a blood flow indicator), and a nozzle 108 .
- the sheath 104 includes a first tube 112 and a first port 114 .
- the first port 114 is partially conical in shape and includes a top opening 118 through which diagnostic or procedural tools (e.g., a positioning catheter) may be introduced into the blood vessel 168 .
- diagnostic or procedural tools e.g., a positioning catheter
- the first tube 112 is defined by a wall 116 (which in this embodiment is annular in shape, but is capable of alternative shapes), a first end 120 located distal (i.e., with respect to the vantage point of the clinician), and a second end 122 located proximal.
- the first port 114 is connected to the first tube 112 at the second end 122 .
- the wall 116 of the sheath 104 defines a first cavity 126 interior thereto.
- the wall 116 further defines a plurality of flush openings 128 located near the first end 120 thereof (present in the dedicated sheath form of the vascular access device 100 only, but not present in the procedure sheath form of the vascular access device 100 ′), an indicator opening 130 , and a nozzle opening 132 , each of which extend through the wall 116 .
- the first tube 112 includes a bottom opening 134 located at the first end 120 , the bottom opening 134 adapted to be placed adjacent the arteriotomy.
- each of the top opening 118 , the flush openings 128 , the indicator opening 130 , the nozzle opening 132 , and the bottom opening 134 are in fluid flow communication with the first cavity 126 of the sheath 104 .
- the wall 116 is eased (e.g., radiused, rounded, chamfered, etc.) at the first end 120 to remove sharp edges, since the first end 120 is designed to be inserted into a tissue tract and into the blood vessel 168 , as well as being placed adjacent an arteriotomy, including in direct physical contact therewith.
- the flush openings 128 are evenly circumferentially arranged about the wall 116 near the first end 120 thereof.
- four flush openings 128 are envisioned, although any number of flush openings could be provided in alternative embodiments, and the flush openings 128 need not be evenly circumferentially arranged about the wall 116 .
- the nozzle opening 132 is located opposite the indicator opening 130 in the wall 116 and at approximately the same position along the length of the first tube 112 , significantly closer to the second end 122 than the first end 120 . Multiple alternative positions for the indicator opening 130 and/or the nozzle opening 132 are possible, as would be understood by a person having ordinary skill in the art. As noted above, no flush openings are present in the procedure sheath form of the vascular access device 100 ′ shown in FIGS. 12-17 .
- the indicator 106 includes a second tube 136 and a second port 138 connected to the second tube 136 at a proximal end thereof.
- the second port 138 is partially conical in shape, although alternative shapes are possible.
- the second tube 136 includes a wall 140 (which in this embodiment is annular in shape, but is capable of alternative shapes) that, along with the second port 138 , defines a second cavity 142 that is in fluid flow communication with the first cavity 126 of the sheath 104 .
- the indicator 106 is mounted to the sheath 104 via the connection of the second tube 136 to the sheath 104 at the indicator opening 130 .
- the indicator 106 is formed of a transparent or translucent material (e.g., polymer plastic and/or glass). Thus, a clinician may view whether blood has traveled up the sheath 104 and is present in the indicator 106 .
- the indicator 106 allows for the clinician to check for blood back flow into the sheath 104 when the sheath 104 is inserted into the blood vessel 168 .
- the indicator 106 may be omitted entirely or provided as a completely separate device.
- the nozzle 108 includes a third tube 146 and a third port 148 attached at a top end 154 (i.e., proximal end) thereof.
- the third port 148 is partially conical in shape, although alternative shapes are possible.
- the third tube 146 includes a wall 150 (which in this embodiment is annular in shape, but is capable of alternative shapes) which, along with the third port 148 , defines a third cavity 152 interior thereto.
- the third tube 146 is flexible and slidably engaged with the sheath 104 such that a bottom end 156 (i.e., distal end) of the third tube 146 may be adjustably relocated either close or remote from the bottom opening 134 of the sheath 104 .
- the third cavity 152 is in fluid flow communication with the first cavity 126 , so that procoagulant and other components (e.g., flushing liquids) may be introduced into the first cavity 126 via the third cavity 152 , as will be further described below.
- the nozzle 108 is slidably engaged with the sheath 104 . More specifically, in operation the length of the third tube 146 may be slid through the wall 116 via the nozzle opening 132 to selectively approach and retract the bottom end 156 of the third tube 146 relative to the first end 120 of the sheath 104 within the first cavity 126 . In addition, in the present embodiment, the third tube 146 may be slidably positioned in the sheath 104 such that the bottom end 156 of the third tube 146 extends beyond the first end 120 of the sheath 104 , through the bottom opening 134 .
- an exemplary body part 160 where a vascular access procedure is to be performed e.g., a leg
- the body part 160 includes skin 164 .
- the body part 160 also includes a blood vessel 168 (e.g., an artery) where the vascular access procedure is to be performed and tissue 166 (e.g., one or more of muscle, fat, connective tissue, fascia, membranous layers, etc.) that surrounds the blood vessel 168 both above (i.e., towards the surface of the skin 164 ) and below.
- tissue 166 e.g., one or more of muscle, fat, connective tissue, fascia, membranous layers, etc.
- bone might instead be located immediately below the targeted blood vessel instead of tissue 166 .
- a properly-executed vascular access procedure involves accessing the interior of the blood vessel 168 (e.g., a fourth cavity 174 ) through a wall 172 thereof, without puncturing through the other side thereof (i.e., puncturing through the blood vessel wall 172 located closer to the skin 164 in FIG. 5 , without puncturing the opposite side of the blood vessel wall 172 located further away from the skin 164 ).
- the blood vessel wall 172 is generally cylindrical and thus has an inner diameter d i and an outer diameter d o .
- a flow of blood B courses through the blood vessel 168 , and exerts outward pressure on the inner diameter d i of the blood vessel wall 172 .
- vascular access procedures are well-known in the art.
- a commonly-used procedure is known as the Seldinger Technique (“ST”).
- ST Seldinger Technique
- a hollow needle cannula
- D 1 first direction
- tissue 166 tissue 166
- blood vessel wall 172 blood vessel wall 172
- a guidewire or leader is introduced in the first direction D 1 through the interior of the hollow needle and placed interior to the blood vessel 168 .
- the hollow needle is then removed from the tissue tract 184 , leaving the guidewire in place to maintain vascular access.
- a procedure sheath is then introduced over the guidewire and into the interior of the blood vessel 168 .
- the procedure sheath is then used to permit the introduction of diagnostic and/or interventional tools into the interior of the blood vessel 168 , which are then removed from the procedure sheath upon completion of the intended procedure(s).
- either the procedure sheath may be used continuously throughout performance of the vascular closure methods discussed herein, or in the alternative the procedure sheath is removed from the tissue tract after the diagnostic and/or interventional procedures have been performed and is replaced with a dedicated sheath prior to the vascular closure steps discussed herein. If a dedicated sheath is to be used for the vascular closure methods, it is first introduced over a guidewire (which will need to be reintroduced, if previously removed) using a dilator to access the interior of the blood vessel 168 , prior to performance of the vascular closure methods discussed herein.
- FIGS. 6A-11 illustrate various steps of a vascular closure method 1006 which comprises the step of filling the sheath 104 with procoagulant close to the arteriotomy 186 , while the sheath 104 is located in a distal position adjacent to (e.g., in direct physical contact with or in close proximity to) the blood vessel 168 .
- a positioning catheter 194 e.g., a balloon catheter
- FIGS. 6A-11 illustrate various steps of a vascular closure method 1006 which comprises the step of filling the sheath 104 with procoagulant close to the arteriotomy 186 , while the sheath 104 is located in a distal position adjacent to (e.g., in direct physical contact with or in close proximity to) the blood vessel 168 .
- a positioning catheter 194 e.g., a balloon catheter
- positioning catheter 194 is slid through the sheath 104 in the first direction D 1 to enter the blood vessel 168 via the tissue tract 184 and the arteriotomy 186 .
- the sheath 104 guides and directs the positioning catheter 194 into the blood vessel 168 , while in its uninflated/unexpanded state.
- the positioning catheter 194 includes a fourth tube 196 connected to a balloon 198 .
- the balloon 198 is selectively inflatable via the fourth tube 196 .
- a portion of the flow of blood B from the blood vessel 168 is able to freely flow through the arteriotomy 186 and into the sheath 104 .
- the balloon 198 is inflated (e.g., with saline and/or air) via the fourth tube 196 and then pulled in the second direction D 2 so that the balloon 198 in its inflated state abuts and seals off the first end 120 of the vascular access device 100 so that no additional blood B can flow into the sheath 104 .
- the sheath 104 and positioning catheter 194 are then simultaneously pulled in the second direction D 2 until the inflated balloon 198 abuts the inner diameter d i of the blood vessel wall 172 and the sheath 104 is located in an extravascular position adjacent the arteriotomy 186 , as shown in FIG. 7 .
- the balloon 198 As the inflated balloon 198 contacts the inner diameter d i , it impedes the flow of blood B from flowing out of blood vessel 168 via the arteriotomy 186 . In other words, the balloon 198 lodges against and covers the inner diameter d i at the arteriotomy 186 , and is held in place in this position for additional steps of the method.
- other types of devices e.g., anchor-type devices
- capable of temporarily sealing the arteriotomy 186 i.e., for performing a temporary sealing step and an unsealing step
- the present application discloses novel methods 1006 , 1106 of performing a vascular closure procedure that involve filling a sheath or the tissue tract with a procoagulant component close to the arteriotomy while the arteriotomy is temporary closed, and then reopening the arteriotomy so that blood exiting a blood vessel through the arteriotomy immediately reacts with the procoagulant located in the sheath or tissue tract.
- vascular closure device 100 may be used to practice these methods, it is not essential that this exact device be employed to perform the methods described herein.
- any suitable device having a sheath with suitably-located flushing opening(s) close to the distal end thereof and a means for delivery of procoagulant close to an arteriotomy could be employed instead, within the spirit and scope of the present disclosure.
- a separate micro-catheter, nozzle, or the fourth tube 196 of the positioning catheter 194 could alternatively be employed to deliver the flushing liquid and/or the procoagulant material to the arteriotomy 186 .
- a positioning catheter could be provided with a nozzle slidably attached to the fourth tube 196 (i.e., primary cavity) thereof that is used to deliver the procoagulant to the arteriotomy, wherein the nozzle has a distal end that is adjustable with respect to the distal end of the primary cavity of the positioning catheter such that the distal end of the nozzle can be adjusted to positions located near, at, and/or beyond the distal end of the primary cavity of the positioning catheter.
- both existing dedicated sheaths and procedure sheaths having one or more distally-located hole(s) located therein could be used to perform the methods 1006 , 1106 according to the present disclosure.
- the flushing fluid or solution F and/or procoagulant material C can be introduced in close proximity to the arteriotomy 186 through a micro catheter or other small nozzle that has been passed through the valve port of a procedure sheath.
- the procoagulant material C is introduced (i.e., in the first direction D 1 ) to the arteriotomy 186 at a pressure less than the combined pressure of the blood pressure in the flow of blood B and the pressure with which the balloon is being pulled against the inner diameter d i of the blood vessel 168 at the arteriotomy 186 (i.e., the combined pressure acting in the second direction D 2 ), to minimize the risk of the procoagulant material C entering the blood vessel 168 and possibly causing an embolic event.
- a flushing fluid F which may be for example saline, an organic solvent, or a procoagulant solution.
- flushing fluid F is injected into the sheath 104 (either via the first port 114 or the third port 148 ), and this flushing fluid F—along with any blood B that has collected within the sheath 104 —flows out of the flush openings 128 and/or the bottom opening 134 into the tissue tract 184 , but preferably does not enter the interior of the blood vessel 168 (and likely will not due to the placement of the inflated balloon 198 and the internal pressure of the flow of blood B through the blood vessel 168 , so long as the flushing fluid F is added at a pressure less than the combined pressure of the balloon 198 as it is being pulled and the blood pressure in the flow of blood B, as noted above).
- procoagulant fluid C is then introduced into the sheath 104 so that it fills the space atop and within the arteriotomy 186 and sits atop the inflated balloon 198 .
- the procoagulant fluid C could be introduced according to any of the following concepts: at multiple points between the distal and proximal ends of the sheath 104 at the same time; at multiple points between the distal and proximal ends of the sheath 104 at different times; while moving the first end 120 of the sheath 104 from the distal side to the proximal side of the tissue tract 184 ; and/or while moving the first end 120 of the sheath 104 from the proximal side to the distal side of the tissue tract 184 .
- the positioning catheter 194 is now removed from the body part 160 . More specifically, the balloon 198 is deflated and pulled in the second direction D 2 , through the pooled procoagulant fluid and out of the vascular access device 100 , thus unsealing the vascular access site.
- the balloon 198 is deflated, a portion of the flow of blood B immediately flows into the arteriotomy 186 , where it makes contact with the procoagulant fluid C, thus starting the coagulation process and forming a partially-coagulated plug 204 .
- the remainder of the procoagulant fluid C located in the sheath 104 will also quickly coagulate, starting at the arteriotomy 186 and continuing proximally towards the skin 164 .
- the vascular access device 100 is now removed from the body part 160 . More specifically, the vascular access device 100 is pulled in the second direction D 2 and completely removed from the tissue tract 184 . If necessary, additional procoagulant material C may optionally be filled within the tissue tract 184 to a level closer to the skin 164 than what is shown in FIGS. 8-11 , including filling the entire tissue tract 184 up to the surface of the skin 164 .
- procoagulant material C is introduced (i.e., in the first direction D 1 ) at a pressure less than the blood pressure in the flow of blood B (i.e., the pressure acting in the second direction D 2 ), to minimize the risk of the procoagulant material C entering the blood vessel 168 and possibly causing an embolic event.
- a bandage 208 may finally be applied to the skin 164 to cover and close the tissue tract 184 at the skin 164 end thereof.
- the plug 204 closes the arteriotomy 186 and the bandage 208 closes the tissue tract 184 .
- FIGS. 12-18 illustrate various steps of an alternative method 1106 of filling the tissue tract 184 with procoagulant close to the arteriotomy 186 , while the sheath 104 ′ has been retracted away from the blood vessel 168 to a proximate position (i.e., spaced apart from the outer diameter d o of the blood vessel 168 ).
- FIG. 12 is substantively identical to FIG. 6A and depicts the introduction of a positioning catheter 194 into the blood vessel 168 via the vascular access device 100 ′, as described in detail above, and
- FIG. 13 is substantively identical to FIG.
- FIG. 6B depicts inflation of the balloon 198 and movement of the balloon 198 to a position in which it abuts and seals off the first end 120 ′ of the vascular access device 100 ′.
- the vascular access device 100 ′ is retracted from the blood vessel 168 in second direction Dz. More specifically, with reference to FIG.
- the vascular access device 100 is moved proximately within the tissue tract 184 , such that the first end 120 ′ of the sheath 104 ′ is located away from the blood vessel 168 in the tissue tract 184 , between the wall 172 of the blood vessel 168 and the skin 164 .
- the tissue tract 184 and the arteriotomy 186 are flushed using the flushing fluid F in the same manner as described above with respect to FIG. 7 .
- the tissue tract 184 may be well flushed to remove blood of the flow of blood B from the first cavity 126 ′ and the entirety of the tissue tract 184 (without any possibility for blood to remain adhered to surfaces of the sheath 104 ′ near the arteriotomy 186 ).
- procoagulant fluid C is introduced after completion of the flushing step via the sheath 104 ′ in the same manner as described above with respect to FIG. 8 , so that the procoagulant material C fills the space atop and within the arteriotomy 186 and sits atop the inflated balloon 198 .
- the procoagulant fluid C could be introduced according to any of the following concepts: at multiple points between the distal and proximal ends of the sheath 104 at the same time; at multiple points between the distal and proximal ends of the sheath 104 at different times; while moving the first end 120 of the sheath 104 from the distal side to the proximal side of the tissue tract 184 ; and/or while moving the first end 120 of the sheath 104 from the proximal side to the distal side of the tissue tract 184 .
- the positioning catheter 194 is now removed from the body part 160 in the same manner as described above with respect to FIG. 9 .
- the balloon 198 is deflated and pulled in the second direction D 2 , through the pooled procoagulant fluid and out of the vascular access device 100 ′.
- a portion of the flow of blood B immediately flows into the arteriotomy 186 , where it makes contact with the procoagulant fluid C, thus starting the coagulation process and forming a partially-coagulated plug 204 .
- the remainder of the procoagulant fluid C located in the sheath 104 will also quickly coagulate, starting at the arteriotomy 186 and continuing proximally towards the skin 164 .
- the vascular access device 100 is removed from the body part 160 in the same manner as described above with respect to FIG. 10 .
- additional procoagulant material C may optionally be filled within the tissue tract 184 to fill most or all of the tissue tract 184 up to the surface of the skin 164 . If additional procoagulant material C is introduced, it may be desirable to ensure that the procoagulant material C is introduced (i.e., in the first direction D 1 ) at a pressure less than the blood pressure in the flow of blood B (i.e., the pressure acting in the second direction D 2 ), to minimize the risk of the procoagulant material C entering the blood vessel 168 and possibly causing an embolic event.
- FIG. 19 is a flowchart of a first exemplary method 1000 to perform a vascular access and closure procedure utilizing a known vascular access method (e.g., the ST) and the vascular closure method illustrated in FIGS. 6A-11 .
- a known vascular access method e.g., the ST
- FIGS. 6A-11 the vascular closure method illustrated in FIGS. 6A-11 .
- the exemplary method 1000 is described with reference to the flowchart illustrated in FIG. 19 , additional or alternative method steps to perform the vascular access and closure procedures are possible. For example, the order of execution of the blocks may be changed, and/or some of the blocks described may be changed, eliminated, or combined.
- the first exemplary method 1000 includes collected process blocks 1002 , 1004 , and 1006 .
- Each of the collected process blocks 1002 , 1004 , and 1006 includes multiple blocks representing individual steps, as will be described in greater detail below.
- the first exemplary method 1000 begins at collected process block 1002 by opening or accessing the blood vessel 168 , for example via use of the ST.
- the first exemplary method 1000 generally continues at collected process block 1004 by performing a procedure within the blood vessel 168 .
- the first exemplary method 1000 generally continues at collected process block 1006 by closing the blood vessel 168 according to the vascular closure method 1006 described herein.
- the collected process block 1002 includes blocks 1008 - 1014 .
- a needle is inserted through tissue 166 into the blood vessel 168 as described above, e.g., in accordance with the ST.
- a guidewire is introduced through the interior of the needle and placed interior to the blood vessel 168 , as described above, e.g., in accordance with the ST.
- the needle is removed over the guidewire, leaving the guidewire in place within the tissue tract 184 and blood vessel 168 to maintain vascular access.
- a procedure sheath is introduced into the tissue tract 184 and blood vessel 168 .
- the collected process block 1004 includes blocks 1018 and 1020 .
- the procedure catheter 190 and/or other tool(s) are used to make an internal repair as described above.
- the procedure catheter 190 is removed from the blood vessel 168 and the tissue tract 184 as described above.
- the collected process block 1006 includes blocks 1022 - 1040 . If a dedicated sheath, e.g., sheath 104 , is to be used to perform the closure method 1006 according to the present disclosure, the procedure sheath, e.g., sheath 104 ′, is removed from the blood vessel 168 and the dedicated sheath is inserted into the blood vessel 168 —shown via block 1021 in FIG. 22 —prior to insertion of the positioning catheter. At block 1022 , the positioning catheter 194 is inserted through the sheath 104 or sheath 104 ′ into the blood vessel 168 as described above with reference to FIG. 6A .
- a dedicated sheath e.g., sheath 104
- the balloon 198 of the positioning catheter 194 is inflated as described above with reference to FIG. 6B and pulled against the distal end of the sheath 104 , 104 ′ while located interior to the blood vessel 168 .
- the balloon 198 of the positioning catheter 194 is lodged against the inner diameter d i of the blood vessel 168 as described above with reference to FIG. 7 .
- the sheath 104 , 104 ′ is lodged against or placed very near the outer diameter outer diameter d o of the blood vessel 168 , and the tissue tract 184 and arteriotomy 186 are flushed using the flushing fluid F as described above with reference to FIG. 7 .
- the procoagulant fluid C is dispensed as described above with reference to FIG. 8 .
- the positioning catheter balloon 198 is deflated as described above with reference to FIG. 9 , which immediately causes blood B from the blood vessel 168 to flow through the arteriotomy 186 and react with the procoagulant fluid C.
- the positioning catheter 194 is removed through the procoagulant fluid C and removed from the sheath 104 , 104 ′ as described above with reference to FIG. 9 .
- the procoagulant fluid C is optionally dispensed again as described above with reference to FIG. 10 .
- the sheath 104 , 104 ′ is removed from the body part 160 as described above with reference to FIG. 10 .
- the bandage 208 is applied to the skin 164 as described above with reference to FIG. 11 , to complete the vascular closure method 1006 .
- FIG. 23 is a flowchart of a second exemplary method 1100 to perform a vascular access and closure procedure utilizing a known vascular access method (e.g., the ST) and the vascular closure method illustrated in FIGS. 12-18 .
- a known vascular access method e.g., the ST
- FIGS. 12-18 the vascular closure method illustrated in FIGS. 12-18 .
- the second exemplary method 1100 is described with reference to the flowchart illustrated in FIG. 23 , additional or alternative method steps to perform the vascular access and closure procedures are possible.
- the order of execution of the blocks may be changed, and/or some of the blocks described may be changed, eliminated, or combined.
- the second exemplary method 1100 includes the collected process blocks 1002 and 1004 as described above with reference to FIGS. 19-21 , and further includes collected process block 1106 .
- the collected process block 1106 includes multiple blocks representing individual steps, as will be described in greater detail below.
- the second exemplary method 1100 begins at collected process block 1002 by opening or accessing the blood vessel 168 , for example via use of the ST.
- the second exemplary method 1100 generally continues at collected process block 1004 by performing a procedure within the blood vessel 168 .
- the second exemplary method 1100 generally continues at collected process block 1106 by closing the blood vessel 168 according to the vascular closure method 1106 described herein.
- the collected process block 1106 includes blocks 1122 - 1142 . If a dedicated sheath, e.g., sheath 104 , is to be used to perform the closure method 1106 according to the present disclosure, the procedure sheath, e.g., sheath 104 ′, is removed from the blood vessel 168 and the dedicated sheath is inserted into the blood vessel 168 —shown via block 1121 in FIG. 24 —prior to insertion of the positioning catheter. At block 1122 , the positioning catheter 194 is inserted through the sheath 104 or sheath 104 ′ into the blood vessel 168 as shown in FIG. 12 and described above with reference to FIG. 6A .
- the balloon 198 of the positioning catheter 194 is inflated as described above with reference to FIG. 13 and pulled against the distal end of the sheath 104 , 104 ′ while located interior to the blood vessel 168 .
- the positioning catheter balloon 198 is lodged against the inner diameter d i of the blood vessel 168 as described above with reference to FIG. 13 .
- the sheath 104 , 104 ′ is retracted from the blood vessel 168 to position the first end 120 , 120 ′ of the sheath 104 , 104 ′ spaced apart from the blood vessel wall 172 in the tissue tract 184 , as described above with reference to FIGS. 13 and 14 .
- the tissue tract 184 and arteriotomy 186 are flushed using the flushing fluid F as described above with reference to FIG. 14 .
- the procoagulant fluid C is dispensed as described above with reference to FIG. 15 .
- the balloon 198 of the positioning catheter 194 is deflated as described above with reference to FIG. 16 , which immediately causes blood B from the blood vessel 168 to flow through the arteriotomy 186 and react with the procoagulant fluid C.
- the positioning catheter 194 is removed through the procoagulant fluid C and removed from the sheath 104 , 104 ′ as described above with reference to FIG. 16 .
- the procoagulant fluid C is optionally dispensed again as described above with reference to FIG. 16 .
- the sheath 104 , 104 ′ is removed from the body part 160 as described above with reference to FIG. 17 .
- the bandage 208 is applied to the skin 164 as described above with reference to FIG. 18 , to complete the vascular closure method 1106 .
Abstract
Description
- The present invention relates to a vascular closure device and related methods for achieving hemostasis at a vascular access site after a surgical procedure.
- Various closure devices and methods to perform surgical procedures via blood vessel access are well known in the art. For example, in some procedures a positioning catheter may be introduced into a blood vessel via a puncture in the blood vessel, and thereafter various procedural tools (e.g., a balloon catheter) may be introduced into the blood vessel via the positioning catheter to perform a procedure at a surgical site located near or some distance away from the puncture. When the procedural tools and positioning catheter are removed, an open puncture in the blood vessel (e.g., an arteriotomy, if the blood vessel is an artery) and an open subcutaneous tissue tract will remain, and require action to prevent the patient from significant blood loss.
- Various intra- and/or extra-vascular solutions for covering and sealing the arteriotomy exist. For those solutions that include an intra-vascular component, there is a risk of this component dislodging and causing an embolism. Moreover, existing solutions that include only an extra-vascular component continue to require manual compression of the access site for several minutes after removal of the devices from the tissue tract. The continued need for manual compression limits the effectiveness of these procedures and increases the time required to perform each procedure. Accordingly, there is a need for a vascular closure device and related methods that address these and other drawbacks of the prior art.
- In one respect, the present disclosure comprises a method of performing a vascular closure procedure at a vascular access site that has been formed through a wall of a blood vessel in a body part of a patient, the method comprising: inserting a sheath into a tissue tract defined in the body part, the tissue tract being in fluid flow communication with an interior of the blood vessel via the vascular access site such that blood from the blood vessel may enter the tissue tract; temporarily sealing the vascular access site so that blood from the blood vessel may no longer enter the tissue tract; flushing the tissue tract with a flushing fluid via the sheath such that the tissue tract is substantially cleared of blood; injecting a procoagulant material into the tissue tract via the sheath at a location adjacent the vascular access site; and unsealing the vascular access site so that blood from the blood vessel interacts with the procoagulant material at the location.
- In another respect, the present disclosure comprises a vascular closure device comprising: a sheath having a wall, the wall defining a cavity, the cavity including a plurality of flush openings located in the wall adjacent a first end of the cavity and a port located at a second end of the cavity, the port and the plurality of flush openings being in fluid flow communication, the sheath being adapted to be inserted within a tissue tract defined in a body part of a patient to a position adjacent a vascular access site formed through a wall of a blood vessel in the body part, the tissue tract being in fluid flow communication with an interior of the blood vessel via the vascular access site such that blood from the blood vessel may enter the tissue tract; wherein, when the sheath is inserted within the tissue tract, a flushing fluid may be introduced into the cavity through the port such that the flushing fluid exits the cavity through the plurality of flush openings such that the sheath and the tissue tract are substantially cleared of blood.
- In yet another respect, the present disclosure comprises a method of performing a vascular closure procedure at a vascular access site that has been formed through a wall of a blood vessel in a body part of a patient, the method comprising: inserting a sheath into a tissue tract defined in the body part, the tissue tract being in fluid flow communication with an interior of the blood vessel via the vascular access site such that blood from the blood vessel may enter the tissue tract; inserting a positioning catheter through the sheath into the blood vessel, the positioning catheter comprising a cavity and a nozzle slidably attached thereto such that a position of a distal end of the nozzle is adjustable with respect to a distal end of the cavity; temporarily sealing the vascular access site so that blood from the blood vessel may no longer enter the tissue tract; flushing the tissue tract with a flushing fluid via the sheath or the nozzle such that the tissue tract is substantially cleared of blood; injecting a procoagulant material into the tissue tract via the nozzle at a location adjacent the vascular access site; and unsealing the vascular access site so that blood from the blood vessel interacts with the procoagulant material at the location.
- The present disclosure will hereinafter be described in conjunction with the appended drawing figures, wherein like numerals denote like elements.
-
FIG. 1 is a front view of an exemplary vascular access device according to an embodiment of the present disclosure; -
FIG. 2 is a side view thereof; -
FIG. 3 is a cross-sectional view thereof, taken along line 3-3 ofFIG. 2 ; -
FIG. 4 is a perspective view of an exemplary body part of a patient where a vascular access procedure may occur; -
FIG. 5 is a partial cross-sectional view of the body part ofFIG. 4 taken along line 5-5 ofFIG. 4 , showing an exemplary blood vessel on which a vascular access procedure will be performed; -
FIGS. 6A and 6B are partial cross-sectional views of the exemplary vascular access device ofFIGS. 1-3 and a positioning catheter in operation to close the blood vessel ofFIG. 5 according to a first vascular closure method of the present disclosure; -
FIG. 7 is a partial cross-sectional view of the exemplary vascular access device ofFIGS. 1-3 and the positioning catheter ofFIGS. 6A and 6B further in operation to close the blood vessel ofFIGS. 5-6B according to the first vascular closure method; -
FIG. 8 is a partial cross-sectional view of the exemplary vascular access device ofFIGS. 1-3 6A, and 6B and the positioning catheter ofFIGS. 6A-7 in yet further operation to close the blood vessel ofFIGS. 5-7 according to the first vascular closure method; -
FIG. 9 is a partial cross-sectional view of the exemplary vascular access device ofFIGS. 1-3 and 6A-8 and the positioning catheter ofFIGS. 6A-8 in even further operation to close the blood vessel ofFIGS. 5-8 according to the first vascular closure method; -
FIG. 10 is a partial cross-sectional view of the exemplary vascular access device ofFIGS. 1-3 and 6A-9 in further operation to close the blood vessel ofFIGS. 5-9 according to the first vascular closure method; -
FIG. 11 is a partial cross-sectional view of a bandage in operation to close the body part ofFIGS. 4-10 according to the first vascular closure method; -
FIG. 12 is a partial cross-sectional view of an alternative vascular access device according to the vascular access device ofFIGS. 1-3 and 6A-10 and the positioning catheter ofFIGS. 6A-9 in operation to close the blood vessel ofFIG. 5 according to a second vascular closure method of the present disclosure; -
FIG. 13 is a partial cross-sectional view of the alternative vascular access device ofFIG. 12 and the positioning catheter ofFIGS. 6A-9 and 12 in operation to close the blood vessel ofFIGS. 5 and 12 according to the second vascular closure method; -
FIG. 14 is a partial cross-sectional view of the alternative vascular access device ofFIGS. 12 and 13 and the positioning catheter ofFIGS. 6A-9, 12, and 13 in further operation to close the blood vessel ofFIGS. 5, 12, and 13 according to the second vascular closure method; -
FIG. 15 is a partial cross-sectional view of the alternative vascular access device ofFIGS. 12-14 and the positioning catheter ofFIGS. 6A-9 and 12-14 in yet further operation to close the blood vessel ofFIGS. 5 and 12-14 according to the second vascular closure method; -
FIG. 16 is a partial cross-sectional view of the alternative vascular access device ofFIGS. 12-15 and the positioning catheter ofFIGS. 6A-9 and 12-15 in even further operation to close the blood vessel ofFIGS. 5 and 12-15 according to the second vascular closure method; -
FIG. 17 is a partial cross-sectional view of the exemplary vascular access device ofFIGS. 12-16 in yet further operation to close the blood vessel ofFIGS. 5 and 12-16 according to the second vascular closure method; -
FIG. 18 is a partial cross-sectional view of the bandage ofFIG. 11 in operation to close the body part ofFIGS. 4-17 according to the second vascular closure method; -
FIG. 19 is a flowchart representative of a first method according to the present disclosure of performing an internal vascular procedure utilizing a known vascular access method and the first vascular closure method ofFIGS. 6A-11 ; -
FIG. 20 illustrates the flowchart ofFIG. 19 with a first block of the flowchart expanded; -
FIG. 21 illustrates the flowchart ofFIG. 19 with a second block of the flowchart expanded; -
FIG. 22 illustrates the flowchart ofFIG. 19 with a third block of the flowchart expanded; -
FIG. 23 is a flowchart representative of a second method according to the present disclosure of performing an internal vascular procedure utilizing a known vascular access method and the second vascular closure method ofFIGS. 12-18 ; and -
FIG. 24 illustrates the flowchart ofFIG. 23 with a block of the flowchart expanded. - The ensuing detailed description provides exemplary embodiment(s) only, and is not intended to limit the scope, applicability, or configuration thereof. Rather, the ensuing detailed description of the exemplary embodiment(s) will provide those skilled in the art with an enabling description for implementing these embodiment(s). It should be understood that various changes may be made in the function and arrangement of elements of the embodiment(s) without departing from the spirit and scope of the invention, as set forth in the appended claims.
- Directional terms (e.g., upper, lower, left, right, etc.) may be used herein. These directional terms are merely intended to assist in disclosing the embodiment(s) and claiming the invention and are not intended to limit the claimed invention in any way. In addition, reference numerals that are introduced in the specification in association with a drawing figure may be repeated in one or more subsequent figure(s) without additional description in the specification, in order to provide context for other features.
- In the specification and accompanying claims, the terms “proximal” and “distal,” unless otherwise specified, should be understood to refer to a frame of reference from the vantage of a surgeon or other clinician using the device or performing the method, with “proximal” referring to a position closer to the clinician and “distal” referring to a position closer to the vascular access site.
- In the specification and accompanying claims, unless otherwise specified, the term “adjacent” should be understood to encompass both “directly in physical contact with” and also “in close proximity to.” For example, with respect to the location within a tissue tract above a vascular access site where a procoagulant material comes into contact with and begins to interact with blood, unless otherwise specified, “adjacent” should be understood to mean a location both in direct physical contact with the vascular access site or otherwise in close proximity thereto.
- The increased prevalence of Peripheral Arterial Disease (PAD) in patients has led to an accompanying increase in the need for peripheral interventions to attempt to clear occlusions from or surgically introduce stents into vascular pathways. Vascular access may be warranted for a number of other reasons, including surgical procedures that are to be performed some distance remote from the vascular access site. After such a procedure is complete, the vascular access site and open tissue tract through which access to the blood vessel was gained must be closed to prevent significant blood loss from the patient.
- Various intra- and/or extra-vascular solutions for covering and sealing an arteriotomy and other vascular access sites (e.g., venous access sites) exist. For those solutions that include an intra-vascular component, there is a risk of this component dislodging and causing an embolism or other complications. Moreover, existing solutions that include only an extra-vascular component continue to require compression of the access site for several minutes after removal of the devices from the tissue tract—whether manually or via a pressure-supplying device (e.g., a band with an inflatable balloon assembly)—because the sealing of the arteriotomy provided by these extra-vascular devices is imperfect such that blood will continue to leak from the arteriotomy. The continued need for the use of compression after the implantation of such extra-vascular closure devices limits the effectiveness of these procedures and increases the amount of time necessary to perform each procedure. Moreover, the imperfect extra-vascular adhesion and sealing caused by existing devices and methods may lead to vascular complications, for example hematomas and pseudoaneurysms.
- Currently, a vascular closure device and related methods that reduce and/or eliminate the need to apply pressure to a vascular access site without the need to leave any sealing component in an intravascular position after a vascular access procedure is not believed to exist. The present disclosure describes a new vascular access device and related methods that are specifically configured to close a vascular access site with little to no application of pressure and without the need to leave an intravascular sealing component.
- The device and methods according to the present disclosure provide improvements through the delivery of procoagulant material (e.g., a fluid or gel) as close as possible to the arteriotomy, which leads to improved adhesion of the partially-coagulated plug of mixed blood and procoagulant to the extravascular portion of the blood vessel atop the arteriotomy, as well as more complete filling of the subcutaneous tissue tract. In both respects, the device and methods according to the present disclosure provide improvements over the known prior art, in which procoagulant is delivered into the tissue tract from a position remote from the arteriotomy (e.g., via a sidearm of a positioning catheter that is located well above the skin surface), which leads to coagulation well up in the cavity of the sheath or tissue tract (i.e., far from the arteriotomy), which is believed to reduce the quality and adhesive effectiveness of the plug formed by the mixed blood and procoagulant material. The inventor has conceived of multiple methods of delivering a procoagulant material at or adjacent to the arteriotomy through various filling and injection methods, which causes the procoagulant material to mix with fresh blood exiting the arteriotomy and results in improved coagulation and reduced or eliminated need for the later application of pressure to the vascular access site to achieve hemostasis.
- The present application discloses various methods of filling the tissue tract with a procoagulant material. A counterpart application having the same named inventor, applicant, and title—and which is being filed on the same date as the present application—discloses various methods of injecting the tissue tract with a procoagulant material. It should be understood that said counterpart application is incorporated herein by reference as if set forth in its entirety.
- The procoagulant material used according to any of the embodiments herein may be in the form of a liquid, viscous liquid, suspension, gel, foam, or a mixture of any thereof. Suitable compounds for the procoagulant material include, but are not limited to, cyanoacrylate (CA), polyurethane, thrombin, a mixture of thrombin and collagen, a mixture of thrombin and gelatin, a mixture of thrombin and fibrinogen, and mixtures of any thereof. The procoagulant material(s) may also be mixed with a solvent, for example but not limited to dimethyl sulfoxide (DMSO), to form a procoagulant mixture that is in a viscous liquid, suspension, gel, or foam form, or a mixture of two or more of these forms. Further, in various methods according to the present disclosure, the solvent and procoagulant may be introduced together into the tissue tract and/or adjacent to the arteriotomy in a variety of orders, for example: the solvent is introduced immediately after the procoagulant material; the procoagulant material is introduced immediately after the solvent; the solvent and procoagulant material are introduced at alternating times in three or more steps (e.g., procoagulant-solvent-procoagulant-etc. or solvent-procoagulant-solvent-etc.; or the procoagulant material and the solvent are introduced simultaneously.
- Referring generally to
FIGS. 1-3 and 6A-10 , a first embodiment of avascular access device 100 according to the above-noted inventive concept will be described in detail below. In addition,FIGS. 12-17 show a second embodiment of avascular access device 100′ according to the above-noted inventive concept. It should be understood that all parts in thevascular access device 100′ bearing the same reference numerals as the respective parts in thevascular access device 100 are functionally identical thereto, unless otherwise discussed herein. Accordingly, thevascular access device 100′ will not be described in detail below, and the discussion below of thevascular access device 100 should be understood to also apply to thevascular access device 100, mutatis mutandis. As shown inFIGS. 1-3 , in this embodiment thevascular access device 100 is designed to deliver blood procoagulant (e.g., via a filling step or injecting step) to a location at or very near a vascular access site, as shown inFIGS. 6A-18 and as would be understood by a person having ordinary skill in the art. With reference toFIGS. 1 and 3 , thevascular access device 100 includes asheath 104, an indicator 106 (e.g., a blood flow indicator), and anozzle 108. - With reference to
FIGS. 1 and 3 , thesheath 104 includes afirst tube 112 and afirst port 114. In this embodiment, thefirst port 114 is partially conical in shape and includes atop opening 118 through which diagnostic or procedural tools (e.g., a positioning catheter) may be introduced into theblood vessel 168. Alternative shapes for thefirst port 114 andtop opening 118 are possible without departing from the scope or spirit of the present disclosure. In the present embodiment, thefirst tube 112 is defined by a wall 116 (which in this embodiment is annular in shape, but is capable of alternative shapes), afirst end 120 located distal (i.e., with respect to the vantage point of the clinician), and asecond end 122 located proximal. Thefirst port 114 is connected to thefirst tube 112 at thesecond end 122. With reference toFIG. 3 , thewall 116 of thesheath 104 defines afirst cavity 126 interior thereto. Thewall 116 further defines a plurality offlush openings 128 located near thefirst end 120 thereof (present in the dedicated sheath form of thevascular access device 100 only, but not present in the procedure sheath form of thevascular access device 100′), anindicator opening 130, and anozzle opening 132, each of which extend through thewall 116. Thefirst tube 112 includes abottom opening 134 located at thefirst end 120, thebottom opening 134 adapted to be placed adjacent the arteriotomy. Each of thetop opening 118, theflush openings 128, the indicator opening 130, thenozzle opening 132, and thebottom opening 134 are in fluid flow communication with thefirst cavity 126 of thesheath 104. In the present embodiment, thewall 116 is eased (e.g., radiused, rounded, chamfered, etc.) at thefirst end 120 to remove sharp edges, since thefirst end 120 is designed to be inserted into a tissue tract and into theblood vessel 168, as well as being placed adjacent an arteriotomy, including in direct physical contact therewith. - Referring again to
FIG. 3 , in this embodiment theflush openings 128 are evenly circumferentially arranged about thewall 116 near thefirst end 120 thereof. In the present embodiment, fourflush openings 128 are envisioned, although any number of flush openings could be provided in alternative embodiments, and theflush openings 128 need not be evenly circumferentially arranged about thewall 116. In the present embodiment, thenozzle opening 132 is located opposite the indicator opening 130 in thewall 116 and at approximately the same position along the length of thefirst tube 112, significantly closer to thesecond end 122 than thefirst end 120. Multiple alternative positions for theindicator opening 130 and/or thenozzle opening 132 are possible, as would be understood by a person having ordinary skill in the art. As noted above, no flush openings are present in the procedure sheath form of thevascular access device 100′ shown inFIGS. 12-17 . - With further reference to
FIG. 3 , theindicator 106 includes asecond tube 136 and asecond port 138 connected to thesecond tube 136 at a proximal end thereof. In this embodiment, thesecond port 138 is partially conical in shape, although alternative shapes are possible. Thesecond tube 136 includes a wall 140 (which in this embodiment is annular in shape, but is capable of alternative shapes) that, along with thesecond port 138, defines asecond cavity 142 that is in fluid flow communication with thefirst cavity 126 of thesheath 104. Theindicator 106 is mounted to thesheath 104 via the connection of thesecond tube 136 to thesheath 104 at theindicator opening 130. In some embodiments, theindicator 106 is formed of a transparent or translucent material (e.g., polymer plastic and/or glass). Thus, a clinician may view whether blood has traveled up thesheath 104 and is present in theindicator 106. Theindicator 106 allows for the clinician to check for blood back flow into thesheath 104 when thesheath 104 is inserted into theblood vessel 168. In alternative embodiments, theindicator 106 may be omitted entirely or provided as a completely separate device. - With further reference to
FIG. 3 , thenozzle 108 includes athird tube 146 and athird port 148 attached at a top end 154 (i.e., proximal end) thereof. In this embodiment, thethird port 148 is partially conical in shape, although alternative shapes are possible. Thethird tube 146 includes a wall 150 (which in this embodiment is annular in shape, but is capable of alternative shapes) which, along with thethird port 148, defines athird cavity 152 interior thereto. In this embodiment, thethird tube 146 is flexible and slidably engaged with thesheath 104 such that a bottom end 156 (i.e., distal end) of thethird tube 146 may be adjustably relocated either close or remote from thebottom opening 134 of thesheath 104. Thethird cavity 152 is in fluid flow communication with thefirst cavity 126, so that procoagulant and other components (e.g., flushing liquids) may be introduced into thefirst cavity 126 via thethird cavity 152, as will be further described below. - Referring still to
FIG. 3 , and as mentioned above, thenozzle 108 is slidably engaged with thesheath 104. More specifically, in operation the length of thethird tube 146 may be slid through thewall 116 via thenozzle opening 132 to selectively approach and retract thebottom end 156 of thethird tube 146 relative to thefirst end 120 of thesheath 104 within thefirst cavity 126. In addition, in the present embodiment, thethird tube 146 may be slidably positioned in thesheath 104 such that thebottom end 156 of thethird tube 146 extends beyond thefirst end 120 of thesheath 104, through thebottom opening 134. - With reference to
FIG. 4 , anexemplary body part 160 where a vascular access procedure is to be performed, e.g., a leg, is illustrated. Thebody part 160 includesskin 164. With reference toFIG. 5 , thebody part 160 also includes a blood vessel 168 (e.g., an artery) where the vascular access procedure is to be performed and tissue 166 (e.g., one or more of muscle, fat, connective tissue, fascia, membranous layers, etc.) that surrounds theblood vessel 168 both above (i.e., towards the surface of the skin 164) and below. In some cases, it should be understood, bone might instead be located immediately below the targeted blood vessel instead oftissue 166. In either scenario, a properly-executed vascular access procedure involves accessing the interior of the blood vessel 168 (e.g., a fourth cavity 174) through awall 172 thereof, without puncturing through the other side thereof (i.e., puncturing through theblood vessel wall 172 located closer to theskin 164 inFIG. 5 , without puncturing the opposite side of theblood vessel wall 172 located further away from the skin 164). Theblood vessel wall 172 is generally cylindrical and thus has an inner diameter di and an outer diameter do. A flow of blood B courses through theblood vessel 168, and exerts outward pressure on the inner diameter di of theblood vessel wall 172. - Various vascular access procedures are well-known in the art. A commonly-used procedure is known as the Seldinger Technique (“ST”). In the first step of the ST, a hollow needle (cannula) is inserted in a first direction D1 (see the arrow indicating the first direction D1 in
FIG. 6A ) through theskin 164,tissue 166, andblood vessel wall 172, thus opening atissue tract 184 in theskin 164 and thetissue 166 and anarteriotomy 186 that is defined in theblood vessel wall 172. In the next step of the ST, a guidewire or leader is introduced in the first direction D1 through the interior of the hollow needle and placed interior to theblood vessel 168. The hollow needle is then removed from thetissue tract 184, leaving the guidewire in place to maintain vascular access. - During known treatment methods, a procedure sheath is then introduced over the guidewire and into the interior of the
blood vessel 168. The procedure sheath is then used to permit the introduction of diagnostic and/or interventional tools into the interior of theblood vessel 168, which are then removed from the procedure sheath upon completion of the intended procedure(s). - In the methods according to the present disclosure, either the procedure sheath may be used continuously throughout performance of the vascular closure methods discussed herein, or in the alternative the procedure sheath is removed from the tissue tract after the diagnostic and/or interventional procedures have been performed and is replaced with a dedicated sheath prior to the vascular closure steps discussed herein. If a dedicated sheath is to be used for the vascular closure methods, it is first introduced over a guidewire (which will need to be reintroduced, if previously removed) using a dilator to access the interior of the
blood vessel 168, prior to performance of the vascular closure methods discussed herein. -
FIGS. 6A-11 illustrate various steps of avascular closure method 1006 which comprises the step of filling thesheath 104 with procoagulant close to thearteriotomy 186, while thesheath 104 is located in a distal position adjacent to (e.g., in direct physical contact with or in close proximity to) theblood vessel 168. With reference toFIG. 6A , as part ofmethod 1006, while thevascular access device 100 is located partially interior to theblood vessel 168, a positioning catheter 194 (e.g., a balloon catheter) is introduced into theblood vessel 168 via thevascular access device 100. More specifically,positioning catheter 194 is slid through thesheath 104 in the first direction D1 to enter theblood vessel 168 via thetissue tract 184 and thearteriotomy 186. Thesheath 104 guides and directs thepositioning catheter 194 into theblood vessel 168, while in its uninflated/unexpanded state. In this embodiment, thepositioning catheter 194 includes afourth tube 196 connected to aballoon 198. As further described below, theballoon 198 is selectively inflatable via thefourth tube 196. During this step, a portion of the flow of blood B from theblood vessel 168 is able to freely flow through thearteriotomy 186 and into thesheath 104. - With reference to
FIG. 6B , in further operation ofmethod 1006, theballoon 198 is inflated (e.g., with saline and/or air) via thefourth tube 196 and then pulled in the second direction D2 so that theballoon 198 in its inflated state abuts and seals off thefirst end 120 of thevascular access device 100 so that no additional blood B can flow into thesheath 104. Thesheath 104 andpositioning catheter 194 are then simultaneously pulled in the second direction D2 until theinflated balloon 198 abuts the inner diameter di of theblood vessel wall 172 and thesheath 104 is located in an extravascular position adjacent thearteriotomy 186, as shown inFIG. 7 . As theinflated balloon 198 contacts the inner diameter di, it impedes the flow of blood B from flowing out ofblood vessel 168 via thearteriotomy 186. In other words, theballoon 198 lodges against and covers the inner diameter di at thearteriotomy 186, and is held in place in this position for additional steps of the method. It should be further understood that, in alternative embodiments according to the present disclosure, other types of devices (e.g., anchor-type devices) capable of temporarily sealing the arteriotomy 186 (i.e., for performing a temporary sealing step and an unsealing step) could be employed instead of an inflatable-balloon type device. - As noted above, the present application discloses
novel methods vascular closure device 100 according to the present disclosure may be used to practice these methods, it is not essential that this exact device be employed to perform the methods described herein. As would be understood by a person having ordinary skill in the art from a review of the present application, any suitable device having a sheath with suitably-located flushing opening(s) close to the distal end thereof and a means for delivery of procoagulant close to an arteriotomy could be employed instead, within the spirit and scope of the present disclosure. For example, a separate micro-catheter, nozzle, or thefourth tube 196 of thepositioning catheter 194 could alternatively be employed to deliver the flushing liquid and/or the procoagulant material to thearteriotomy 186. In an alternative example, a positioning catheter could be provided with a nozzle slidably attached to the fourth tube 196 (i.e., primary cavity) thereof that is used to deliver the procoagulant to the arteriotomy, wherein the nozzle has a distal end that is adjustable with respect to the distal end of the primary cavity of the positioning catheter such that the distal end of the nozzle can be adjusted to positions located near, at, and/or beyond the distal end of the primary cavity of the positioning catheter. Further, both existing dedicated sheaths and procedure sheaths having one or more distally-located hole(s) located therein could be used to perform themethods methods arteriotomy 186 through a micro catheter or other small nozzle that has been passed through the valve port of a procedure sheath. Further, in some embodiments according to thepresent methods arteriotomy 186 at a pressure less than the combined pressure of the blood pressure in the flow of blood B and the pressure with which the balloon is being pulled against the inner diameter di of theblood vessel 168 at the arteriotomy 186 (i.e., the combined pressure acting in the second direction D2), to minimize the risk of the procoagulant material C entering theblood vessel 168 and possibly causing an embolic event. - Referring back to
FIG. 7 , in further operation ofmethod 1006, while theballoon 198 remains inflated against the interior side of thearteriotomy 186, thetissue tract 184 and thearteriotomy 186 are flushed using a flushing fluid F, which may be for example saline, an organic solvent, or a procoagulant solution. More specifically, flushing fluid F is injected into the sheath 104 (either via thefirst port 114 or the third port 148), and this flushing fluid F—along with any blood B that has collected within thesheath 104—flows out of theflush openings 128 and/or thebottom opening 134 into thetissue tract 184, but preferably does not enter the interior of the blood vessel 168 (and likely will not due to the placement of theinflated balloon 198 and the internal pressure of the flow of blood B through theblood vessel 168, so long as the flushing fluid F is added at a pressure less than the combined pressure of theballoon 198 as it is being pulled and the blood pressure in the flow of blood B, as noted above). As a result of this step, little to no blood will remain in thesheath 104 ortissue tract 184 because thearteriotomy 186 is temporarily sealed. With reference toFIG. 8 , in further operation ofmethod 1006, procoagulant fluid C is then introduced into thesheath 104 so that it fills the space atop and within thearteriotomy 186 and sits atop theinflated balloon 198. - In various alternative embodiments according to the present disclosure, the procoagulant fluid C could be introduced according to any of the following concepts: at multiple points between the distal and proximal ends of the
sheath 104 at the same time; at multiple points between the distal and proximal ends of thesheath 104 at different times; while moving thefirst end 120 of thesheath 104 from the distal side to the proximal side of thetissue tract 184; and/or while moving thefirst end 120 of thesheath 104 from the proximal side to the distal side of thetissue tract 184. - With reference to
FIG. 9 , in further operation ofmethod 1006, thepositioning catheter 194 is now removed from thebody part 160. More specifically, theballoon 198 is deflated and pulled in the second direction D2, through the pooled procoagulant fluid and out of thevascular access device 100, thus unsealing the vascular access site. When theballoon 198 is deflated, a portion of the flow of blood B immediately flows into thearteriotomy 186, where it makes contact with the procoagulant fluid C, thus starting the coagulation process and forming a partially-coagulatedplug 204. The remainder of the procoagulant fluid C located in thesheath 104 will also quickly coagulate, starting at thearteriotomy 186 and continuing proximally towards theskin 164. - With reference to
FIG. 10 , in further operation ofmethod 1006, thevascular access device 100 is now removed from thebody part 160. More specifically, thevascular access device 100 is pulled in the second direction D2 and completely removed from thetissue tract 184. If necessary, additional procoagulant material C may optionally be filled within thetissue tract 184 to a level closer to theskin 164 than what is shown inFIGS. 8-11 , including filling theentire tissue tract 184 up to the surface of theskin 164. If additional procoagulant material is introduced, it may be desirable to ensure that the procoagulant material C is introduced (i.e., in the first direction D1) at a pressure less than the blood pressure in the flow of blood B (i.e., the pressure acting in the second direction D2), to minimize the risk of the procoagulant material C entering theblood vessel 168 and possibly causing an embolic event. - With reference to
FIG. 11 , abandage 208 may finally be applied to theskin 164 to cover and close thetissue tract 184 at theskin 164 end thereof. Thus, theplug 204 closes thearteriotomy 186 and thebandage 208 closes thetissue tract 184. -
FIGS. 12-18 illustrate various steps of analternative method 1106 of filling thetissue tract 184 with procoagulant close to thearteriotomy 186, while thesheath 104′ has been retracted away from theblood vessel 168 to a proximate position (i.e., spaced apart from the outer diameter do of the blood vessel 168).FIG. 12 is substantively identical toFIG. 6A and depicts the introduction of apositioning catheter 194 into theblood vessel 168 via thevascular access device 100′, as described in detail above, andFIG. 13 is substantively identical toFIG. 6B and depicts inflation of theballoon 198 and movement of theballoon 198 to a position in which it abuts and seals off thefirst end 120′ of thevascular access device 100′. With reference now toFIG. 14 , as an alternative tomethod 1006 discussed above, in thepresent method 1106, after theballoon 198 is inflated and positioned to engage the inner diameter di of theblood vessel 168 at thearteriotomy 186, thevascular access device 100′ is retracted from theblood vessel 168 in second direction Dz. More specifically, with reference toFIG. 14 , thevascular access device 100 is moved proximately within thetissue tract 184, such that thefirst end 120′ of thesheath 104′ is located away from theblood vessel 168 in thetissue tract 184, between thewall 172 of theblood vessel 168 and theskin 164. - Referring still to
FIG. 14 , in further operation ofmethod 1106, thetissue tract 184 and thearteriotomy 186 are flushed using the flushing fluid F in the same manner as described above with respect toFIG. 7 . By positioning thefirst end 120′ away from theblood vessel 168 in thetissue tract 184, thetissue tract 184 may be well flushed to remove blood of the flow of blood B from thefirst cavity 126′ and the entirety of the tissue tract 184 (without any possibility for blood to remain adhered to surfaces of thesheath 104′ near the arteriotomy 186). - With reference to
FIG. 15 , in further operation ofmethod 1106, procoagulant fluid C is introduced after completion of the flushing step via thesheath 104′ in the same manner as described above with respect toFIG. 8 , so that the procoagulant material C fills the space atop and within thearteriotomy 186 and sits atop theinflated balloon 198. - In various alternative embodiments according to the present disclosure, the procoagulant fluid C could be introduced according to any of the following concepts: at multiple points between the distal and proximal ends of the
sheath 104 at the same time; at multiple points between the distal and proximal ends of thesheath 104 at different times; while moving thefirst end 120 of thesheath 104 from the distal side to the proximal side of thetissue tract 184; and/or while moving thefirst end 120 of thesheath 104 from the proximal side to the distal side of thetissue tract 184. - With reference to
FIG. 16 , in further operation ofmethod 1106, thepositioning catheter 194 is now removed from thebody part 160 in the same manner as described above with respect toFIG. 9 . Specifically, theballoon 198 is deflated and pulled in the second direction D2, through the pooled procoagulant fluid and out of thevascular access device 100′. When theballoon 198 is deflated, a portion of the flow of blood B immediately flows into thearteriotomy 186, where it makes contact with the procoagulant fluid C, thus starting the coagulation process and forming a partially-coagulatedplug 204. The remainder of the procoagulant fluid C located in thesheath 104 will also quickly coagulate, starting at thearteriotomy 186 and continuing proximally towards theskin 164. - With reference to
FIG. 17 , in further operation ofmethod 1106, thevascular access device 100 is removed from thebody part 160 in the same manner as described above with respect toFIG. 10 . If necessary, additional procoagulant material C may optionally be filled within thetissue tract 184 to fill most or all of thetissue tract 184 up to the surface of theskin 164. If additional procoagulant material C is introduced, it may be desirable to ensure that the procoagulant material C is introduced (i.e., in the first direction D1) at a pressure less than the blood pressure in the flow of blood B (i.e., the pressure acting in the second direction D2), to minimize the risk of the procoagulant material C entering theblood vessel 168 and possibly causing an embolic event. - Finally, with reference to
FIG. 18 , thebandage 208 may be applied to theskin 164 to cover and close thetissue tract 184 in the same manner as described above with respect toFIG. 11 .FIG. 19 is a flowchart of a firstexemplary method 1000 to perform a vascular access and closure procedure utilizing a known vascular access method (e.g., the ST) and the vascular closure method illustrated inFIGS. 6A-11 . Further, although theexemplary method 1000 is described with reference to the flowchart illustrated inFIG. 19 , additional or alternative method steps to perform the vascular access and closure procedures are possible. For example, the order of execution of the blocks may be changed, and/or some of the blocks described may be changed, eliminated, or combined. - With reference to
FIG. 19 , the firstexemplary method 1000 includes collected process blocks 1002, 1004, and 1006. Each of the collected process blocks 1002, 1004, and 1006 includes multiple blocks representing individual steps, as will be described in greater detail below. Generally, the firstexemplary method 1000 begins at collectedprocess block 1002 by opening or accessing theblood vessel 168, for example via use of the ST. Next, the firstexemplary method 1000 generally continues at collectedprocess block 1004 by performing a procedure within theblood vessel 168. Then, the firstexemplary method 1000 generally continues at collectedprocess block 1006 by closing theblood vessel 168 according to thevascular closure method 1006 described herein. - With reference to
FIG. 20 , the collectedprocess block 1002 includes blocks 1008-1014. Atblock 1008, a needle is inserted throughtissue 166 into theblood vessel 168 as described above, e.g., in accordance with the ST. Atblock 1010, a guidewire is introduced through the interior of the needle and placed interior to theblood vessel 168, as described above, e.g., in accordance with the ST. Atblock 1012, the needle is removed over the guidewire, leaving the guidewire in place within thetissue tract 184 andblood vessel 168 to maintain vascular access. Finally, atblock 1014, a procedure sheath is introduced into thetissue tract 184 andblood vessel 168. - With reference to
FIG. 21 , the collectedprocess block 1004 includesblocks block 1018, the procedure catheter 190 and/or other tool(s) are used to make an internal repair as described above. Atblock 1020, the procedure catheter 190 is removed from theblood vessel 168 and thetissue tract 184 as described above. - With reference to
FIG. 22 , the collectedprocess block 1006 includes blocks 1022-1040. If a dedicated sheath, e.g.,sheath 104, is to be used to perform theclosure method 1006 according to the present disclosure, the procedure sheath, e.g.,sheath 104′, is removed from theblood vessel 168 and the dedicated sheath is inserted into theblood vessel 168—shown viablock 1021 inFIG. 22 —prior to insertion of the positioning catheter. Atblock 1022, thepositioning catheter 194 is inserted through thesheath 104 orsheath 104′ into theblood vessel 168 as described above with reference toFIG. 6A . - At
block 1024, theballoon 198 of thepositioning catheter 194 is inflated as described above with reference toFIG. 6B and pulled against the distal end of thesheath blood vessel 168. Atblock 1026, theballoon 198 of thepositioning catheter 194 is lodged against the inner diameter di of theblood vessel 168 as described above with reference toFIG. 7 . Atblock 1028, thesheath blood vessel 168, and thetissue tract 184 andarteriotomy 186 are flushed using the flushing fluid F as described above with reference toFIG. 7 . Atblock 1030, the procoagulant fluid C is dispensed as described above with reference toFIG. 8 . - At
block 1032, thepositioning catheter balloon 198 is deflated as described above with reference toFIG. 9 , which immediately causes blood B from theblood vessel 168 to flow through thearteriotomy 186 and react with the procoagulant fluid C. Atblock 1034, thepositioning catheter 194 is removed through the procoagulant fluid C and removed from thesheath FIG. 9 . Atblock 1036, if blood oozing is confirmed, the procoagulant fluid C is optionally dispensed again as described above with reference toFIG. 10 . Atblock 1038, thesheath body part 160 as described above with reference toFIG. 10 . Finally, atblock 1040, thebandage 208 is applied to theskin 164 as described above with reference toFIG. 11 , to complete thevascular closure method 1006. -
FIG. 23 is a flowchart of a secondexemplary method 1100 to perform a vascular access and closure procedure utilizing a known vascular access method (e.g., the ST) and the vascular closure method illustrated inFIGS. 12-18 . Further, although the secondexemplary method 1100 is described with reference to the flowchart illustrated inFIG. 23 , additional or alternative method steps to perform the vascular access and closure procedures are possible. For example, the order of execution of the blocks may be changed, and/or some of the blocks described may be changed, eliminated, or combined. - With reference to
FIG. 23 , the secondexemplary method 1100 includes the collected process blocks 1002 and 1004 as described above with reference toFIGS. 19-21 , and further includes collectedprocess block 1106. The collectedprocess block 1106 includes multiple blocks representing individual steps, as will be described in greater detail below. Generally, the secondexemplary method 1100 begins at collectedprocess block 1002 by opening or accessing theblood vessel 168, for example via use of the ST. Next, the secondexemplary method 1100 generally continues at collectedprocess block 1004 by performing a procedure within theblood vessel 168. Then, the secondexemplary method 1100 generally continues at collectedprocess block 1106 by closing theblood vessel 168 according to thevascular closure method 1106 described herein. - With reference to
FIG. 24 , the collectedprocess block 1106 includes blocks 1122-1142. If a dedicated sheath, e.g.,sheath 104, is to be used to perform theclosure method 1106 according to the present disclosure, the procedure sheath, e.g.,sheath 104′, is removed from theblood vessel 168 and the dedicated sheath is inserted into theblood vessel 168—shown via block 1121 inFIG. 24 —prior to insertion of the positioning catheter. Atblock 1122, thepositioning catheter 194 is inserted through thesheath 104 orsheath 104′ into theblood vessel 168 as shown inFIG. 12 and described above with reference toFIG. 6A . - At
block 1124, theballoon 198 of thepositioning catheter 194 is inflated as described above with reference toFIG. 13 and pulled against the distal end of thesheath blood vessel 168. Atblock 1126, thepositioning catheter balloon 198 is lodged against the inner diameter di of theblood vessel 168 as described above with reference toFIG. 13 . - At
block 1128, thesheath blood vessel 168 to position thefirst end sheath blood vessel wall 172 in thetissue tract 184, as described above with reference toFIGS. 13 and 14 . Atblock 1130, thetissue tract 184 andarteriotomy 186 are flushed using the flushing fluid F as described above with reference toFIG. 14 . Atblock 1132, the procoagulant fluid C is dispensed as described above with reference toFIG. 15 . - At
block 1134, theballoon 198 of thepositioning catheter 194 is deflated as described above with reference toFIG. 16 , which immediately causes blood B from theblood vessel 168 to flow through thearteriotomy 186 and react with the procoagulant fluid C. Atblock 1136, thepositioning catheter 194 is removed through the procoagulant fluid C and removed from thesheath FIG. 16 . Atblock 1138, if blood oozing is confirmed, the procoagulant fluid C is optionally dispensed again as described above with reference toFIG. 16 . Atblock 1140, thesheath body part 160 as described above with reference toFIG. 17 . Finally, atblock 1142, thebandage 208 is applied to theskin 164 as described above with reference toFIG. 18 , to complete thevascular closure method 1106. - Within this specification, embodiments have been described in a way which enables a clear and concise specification to be written, but it is intended and will be appreciated that embodiments may be variously combined or separated without departing from the inventive concept. For example, it will be appreciated that all preferred features described herein are applicable to all aspects of the inventive concept described herein.
- Thus, while the inventive concept has been described in connection with particular embodiments and examples, the inventive concept is not necessarily so limited, and that numerous other embodiments, examples, uses, modifications, and departures from the embodiments, examples, and uses are intended to be encompassed by the claims attached hereto. Further, the entire disclosure of each patent and publication cited herein is incorporated by reference as if each such patent or publication were individually incorporated by reference herein.
- While the principles of the claimed invention have been described above in connection with specific embodiment(s), it is to be clearly understood that this description is made only by way of example and not as a limitation of the scope of the invention, as set forth in the appended claims.
Claims (29)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/864,865 US11766544B2 (en) | 2020-05-01 | 2020-05-01 | Vascular closure device and related methods |
PCT/US2021/030323 WO2021222850A1 (en) | 2020-05-01 | 2021-04-30 | Vascular closure device and related methods |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/864,865 US11766544B2 (en) | 2020-05-01 | 2020-05-01 | Vascular closure device and related methods |
Publications (2)
Publication Number | Publication Date |
---|---|
US20210338988A1 true US20210338988A1 (en) | 2021-11-04 |
US11766544B2 US11766544B2 (en) | 2023-09-26 |
Family
ID=78292278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/864,865 Active 2041-04-10 US11766544B2 (en) | 2020-05-01 | 2020-05-01 | Vascular closure device and related methods |
Country Status (2)
Country | Link |
---|---|
US (1) | US11766544B2 (en) |
WO (1) | WO2021222850A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486195A (en) * | 1993-07-26 | 1996-01-23 | Myers; Gene | Method and apparatus for arteriotomy closure |
US6287323B1 (en) * | 1993-09-28 | 2001-09-11 | Hemodynamics, Inc. | Method of catheterization and inhibition of arterial bleeding |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6056768A (en) | 1992-01-07 | 2000-05-02 | Cates; Christopher U. | Blood vessel sealing system |
US5951583A (en) | 1993-05-25 | 1999-09-14 | Vascular Solutions, Inc. | Thrombin and collagen procoagulant and process for making the same |
US6017359A (en) | 1993-05-25 | 2000-01-25 | Vascular Solutions, Inc. | Vascular sealing apparatus |
US5626601A (en) | 1995-10-27 | 1997-05-06 | Gary Gershony | Vascular sealing apparatus and method |
US5868778A (en) | 1995-10-27 | 1999-02-09 | Vascular Solutions, Inc. | Vascular sealing apparatus and method |
US6626918B1 (en) | 2000-10-06 | 2003-09-30 | Medical Technology Group | Apparatus and methods for positioning a vascular sheath |
US9282953B2 (en) | 2007-12-31 | 2016-03-15 | St. Jude Medical Puerto Rico Llc | Systems and methods for locating and closing a tissue puncture |
AU2011253475B2 (en) | 2010-05-12 | 2014-08-14 | St. Jude Medical, Inc. | Bioadhesive applicator and methods of sealing tissue punctures using same |
-
2020
- 2020-05-01 US US16/864,865 patent/US11766544B2/en active Active
-
2021
- 2021-04-30 WO PCT/US2021/030323 patent/WO2021222850A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486195A (en) * | 1993-07-26 | 1996-01-23 | Myers; Gene | Method and apparatus for arteriotomy closure |
US6287323B1 (en) * | 1993-09-28 | 2001-09-11 | Hemodynamics, Inc. | Method of catheterization and inhibition of arterial bleeding |
Also Published As
Publication number | Publication date |
---|---|
WO2021222850A1 (en) | 2021-11-04 |
US11766544B2 (en) | 2023-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6296658B1 (en) | Vascular sealing apparatus | |
EP1442709B1 (en) | Vascular sealant delivery device and sheath indroducer | |
US11534150B2 (en) | Apparatus and methods for sealing a vascular puncture | |
JP2656689B2 (en) | Wound coagulation device | |
US5383896A (en) | Vascular sealing device | |
US5728134A (en) | Method and apparatus for hemostasis | |
JP4564964B2 (en) | Locator and closure device and method of use | |
EP1307141B1 (en) | Apparatus for closing vascular puncture | |
US5626601A (en) | Vascular sealing apparatus and method | |
US5868778A (en) | Vascular sealing apparatus and method | |
US20050149117A1 (en) | Apparatus and methods for delivering sealing materials during a percutaneous procedure to facilitate hemostasis | |
US20070060950A1 (en) | Apparatus and methods for delivering sealing materials during a percutaneous procedure to facilitate hemostasis | |
US20060116635A1 (en) | Arterial closure device | |
US20080046005A1 (en) | Method and apparatus for percutaneous wound sealing | |
JPH07227423A (en) | Wound treating device | |
US10952710B2 (en) | Balloon closure device | |
US20080086109A1 (en) | Arterial closure device | |
JP2005534389A (en) | Device for sealing a puncture hole by reducing the perimeter of the puncture hole | |
US11766544B2 (en) | Vascular closure device and related methods | |
US11690607B2 (en) | Vascular closure device and related methods | |
US20210204925A1 (en) | Balloon closure device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: TERUMO MEDICAL CORPORATION, NEW JERSEY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KOJIMA, JUNYA;REEL/FRAME:052552/0031 Effective date: 20200428 |
|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
CC | Certificate of correction |